[Efficacy of therapy with anti-CD20 antibody (rituximab) in a patient with autoimmune hemolytic anemia associated].
Barquero-Romero
José
J
García Domínguez
Manuel
M
Pérez Miranda
Manuel
M
D000743:Anemia, Hemolytic / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D001323:Autoantibodies / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D001323:Autoantibodies; D000069283:Rituximab